Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, Neuland Laboratories has informed that it enclosed copies of newspaper advertisement regarding the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022, as published in Financial Express and Andhra Prabha on February 14, 2023.
The above information is a part of company’s filings submitted to BSE.